Malkasian Gd
About
In The Last Decade
Malkasian Gd
32 papers receiving 662 citations
Peers
Comparison fields: 5 of 68
- Reproductive Medicine 495
- Obstetrics and Gynecology 228
- Surgery 227
- Oncology 121
- Pathology and Forensic Medicine 98
Countries citing papers authored by Malkasian Gd
This map shows the geographic impact of Malkasian Gd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Malkasian Gd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Malkasian Gd more than expected).
Fields of papers citing papers by Malkasian Gd
This network shows the impact of papers produced by Malkasian Gd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Malkasian Gd. The network helps show where Malkasian Gd may publish in the future.
Co-authorship network of co-authors of Malkasian Gd
This figure shows the co-authorship network connecting the top 25 collaborators of Malkasian Gd. A scholar is included among the top collaborators of Malkasian Gd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Malkasian Gd. Malkasian Gd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 28 | |
| 2 | Gynecologic carcinoma associated with dermatomyositis-polymyositis. | 41 |
| 3 | Cyclophosphamide plus cis-platinum in combination: treatment program for stage III or IV ovarian carcinoma. | 110 |
| 4 | Endometrial carcinoma comparison of Olmsted County and Mayo Clinic referral patients. | 7 |
| 5 | Medroxyprogesterone acetate for the treatment of metastatic and recurrent ovarian carcinoma. | 30 |
| 6 | Prognostic importance of histologic grading in ovarian carcinoma. | 30 |
| 7 | Histology of epithelial tumors of the ovary: clinical usefulness and prognostic significance of the histologic classification and grading. | 50 |
| 8 | Observations on chemotherapy of granulosa cell carcinomas and malignant ovarian teratomas. | 39 |
| 9 | Factors influencing ovarian cancer survival after chemotherapy. | 9 |
| 10 | 6-Dehydro-6,17 alpha-dimethylprogesterone (NSC-123018) for the treatment of metastatic and recurrent ovarian carcinoma. | 12 |
| 11 | Postmenopausal bleeding from atrophic endometrium. | 6 |
| 12 | Chemotherapy of squamous cell carcinoma of the cervix, vagina, and vulva. | 10 |
| 13 | Benign cystic teratomas. | 20 |
| 14 | [Cyclophosphamide as adjuvant treatment of the advanced ovarian carcinoma]. | 1 |
| 15 | Endometriosis associated with complete or partial obstruction of menstrual egress. Report of 7 cases. | 9 |
| 16 | Functioning tumors of the ovary in women under 40. | 9 |
| 17 | TOTAL IRON-BINDING CAPACITY IN NORMAL PREGNANCY. | 1 |
| 18 | TREATMENT OF THE UNILATERAL ENCAPSULATED OVARIAN DISGERMINOMA. | 25 |
| 19 | GRANULOSA-CELL TUMOR OF THE OVARY: REPORT OF A CASE. | 1 |
| 20 | PLACENTA PREVIA PERCRETA. | 5 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.